Tissue Genomic DNA, Breast
CNY 1990.00
| Cited in 1 publication. |
New! ER, PR and HER2 in Clinical Info.
CNY 8080.00
New! ER, PR and HER2 in Clinical Info.
CNY 8080.00
Specifications
| Product Data | |
| Disease State | Cancer |
| Diagnosis Category | Breast Cancer |
| Tissue | Breast |
| Frozen Sample ID | FR5B33FF09 |
| Case ID | CI0000012655 |
| Prep | B |
| Vial ID | DN0000113A |
| Tissue of Origin | Breast |
| Site of Finding | Breast |
| Appearance | Tumor |
| Sample Diagnosis (from Pathology Verification) | Adenocarcinoma of breast, ductal |
| Normal | 5% |
| Lesional | 0% |
| Tumor | 60% |
| Tumor Hypo/Acellular Stroma | 25% |
| Tumor Hypercellular Stroma | 10% |
| Necrosis | 0% |
| Pathology Verification notes from H&E review | cellular tumor stroma: 100% mixed inflammatory cells. hypo/acellular tumor stroma: 100% fibrosis |
| Bioanalyzer Ratio (28S/18S) | 2.11 |
| CASE Diagnosis (from medical center path report) | Adenocarcinoma of breast, ductal |
| Age | 71 |
| Gender | Female |
| Race | White or Caucasian |
| Tumor Grade | Nottingham G3: 8-9 points High combined grade (unfavorable) |
| Minimum Stage Grouping | IIB |
| T (Extent of Primary Tumor) | T2 |
| N (Lymph node metastasis) | N1c |
| M (Distant metastasis) | M0 |
| Diagnostic Test Results | Progesterone receptor ~ PR ! by IHC,Positive, weak; Estrogen receptor ~ ER ! by IHC,Positive; HER2 ~ ERBB2 ~ Neu ! by IHC,Positive, strong |
Citations (1)
| The use of this Tissues has been cited in the following citations: |
|---|
|
Comparison of custom capture for targeted next-generation DNA sequencing
,Samorodnitsky, E;Datta, J;Jewell, BM;Hagopian, R;Miya, J;Wing, MR;Damodaran, S;Lippus, JM;Reeser, JW;Bhatt, D;Timmers, CD;Roychowdhury, S;,
J Mol Diagn
,PubMed ID 25528188
[CD563715]
|
Documents
| SDS |
